No Data
Canature Health Technology (300272.SZ): has begun to integrate large model systems from the business side, office systems, and other areas.
On February 21, Gelonghui reported that Canature Health Technology (300272.SZ) stated on the investor interaction platform that the company has begun to integrate large model systems from the business end, office systems, and other areas.
Canature Health Technology (300272.SZ): The products mainly include water purification related products and do not involve Medical AI.
On February 21, Gelonghui reported that Canature Health Technology (300272.SZ) stated on the investor interaction platform that the company's products mainly consist of water purification related products and do not involve AI Medical. The subsidiary, Yuan Neng Cells, focuses on the upstream and downstream fields of cell storage and has incubated a series of ecological enterprises. In the face of AI, it will undoubtedly embrace it positively, integrating it with scenarios and actively applying it.
Canature Health Technology (300272.SZ): Renewed the House Rental contract with the original partner.
Globe Exchange reported on December 30 that Canature Health Technology (300272.SZ) announced that in order to meet the needs of production, operation, and overall development, the company has recently renewed the "House Rental Contract" with Shanghai Yuan Yi Neng Asia Vets Manufacturing Co., Ltd. (referred to as "Yuan Yi Neng"). The company will rent from Yuan Yi Neng an area of 28,434.29 square meters for office, workshop, three-dimensional storage, basement, etc., at an annual rent of 14.6106 million yuan for a lease term of three years.
Canature Health Technology (300272.SZ): plans to delay the "Intelligent Upgrade and Expansion Project of Health Water Purification Equipment Production Line" until November 30, 2026.
On December 30, Gelonghui reported that Canature Health Technology (300272.SZ) announced its sixth Board of Directors' nineteenth meeting and the sixth Supervisory Board's sixteenth meeting to be held on December 30, 2024. They reviewed and approved the proposal on the postponement of some fundraising investment projects, agreeing to extend the time for the "Health Purification Equipment Production Line Intelligent Upgrade and Expansion Project" to reach the expected usable status until November 30, 2026, provided that there are no changes in the project implementation entity, implementation method, use of raised funds, and investment scale.
Canature Health Technology (300272.SZ) plans to distribute a mid-term profit allocation of 0.7 yuan for every 10 shares in the second distribution of 2024.
Canature Health Technology (300272.SZ) disclosed the second mid-term profit distribution plan for 2024, the company intends to distribute... for every 10 shares...
Canature Health Technology (300272.SZ): Overseas revenue generally accounts for about 65% of total annual revenue.
Gelonghui November 15th | Canature Health Technology (300272.SZ) stated during an investor survey on November 15, 2024 that overseas income generally accounts for about 65% of the total annual income. Currently, the company has already reached OEM production agreements or sales framework agreements with several important long-term overseas clients, with the potential to continue leveraging synergies to support the continuous increase in overseas market share.
Canature Health Technology Co., Ltd. (SZSE:300272) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough
